Search results
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters via Yahoo News· 5 days agoModerna said on Monday its combination vaccine to protect against both COVID-19 and influenza...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 5 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - The Boston Globe
The Boston Globe· 5 days agoModerna said its combination flu and Covid shot met the goals of a pivotal late-stage trial,...
Moderna, Inc. (NASDAQ:MRNA) Director Sells $30,088,098.88 in Stock
ETF DAILY NEWS· 3 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 202,832 shares of the stock in a transaction that occurred on Tuesday, June 11th. The shares were ...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine
Fox Bangor· 5 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 5 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 3 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season
FierceBiotech· 5 days agoModerna’s combo flu and COVID-19 vaccine zipped through a late-stage trial this winter, and the...
Moderna says its combination Covid and flu vaccine works well in late-stage trial
NBC NEWS· 5 days agoModerna said on Monday its combination vaccine to protect against both Covid and influenza generated...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 2 days ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...